Efficacy and safety of AVT-01 10 mg once daily over 7 days in patients with moderate persistent atopic asthma – A double-blind, randomized, placebo-controlled clinical study
Efficacy and safety of AVT-01 10 mg single dose in patients with mild asthma challenged with inhaled tumor necrosis factor alpha – A double-blind, randomized, placebo-controlled clinical study
A multicenter, randomized, double-blind, placebo-controlled, intraindividual-comparison phase IIa trial to evaluate the efficacy and safety of 2% AVT-02 UE ointment in an every other day treatment of mild to moderate psoriasis vulgaris
100 Clinical Results associated with Avontec GmbH
0 Patents (Medical) associated with Avontec GmbH
100 Deals associated with Avontec GmbH
100 Translational Medicine associated with Avontec GmbH